| |
| |
|
| Insider
Information: |
Temasek Holdings Ltd |
| Relationship: |
10% Owner |
| City: |
Singapore 06881 |
| State: |
U0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
14 |
|
| Direct
Shares |
46,584,636 |
|
|
Indirect Shares
|
158,620,461 |
|
|
| Direct
Value |
$668,733,069 |
|
|
|
Indirect Value
|
$3,393,149,108 |
|
|
| Total
Shares |
205,205,097 |
|
|
| Total
Value |
$4,061,882,176 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 19.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Equinix Inc |
EQIX |
10% Owner |
2003-11-21 |
0 |
2008-11-18 |
656,180 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2009-05-21 |
4,035,424 |
|
0 |
Premium* |
|
|
Level 3 Communications Inc |
LVLT |
10% Owner |
2017-11-01 |
0 |
2012-05-10 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
10% Owner |
2017-06-01 |
4,133,568 |
2015-12-09 |
6,583,568 |
Premium* |
|
|
Univar Inc. |
UNVR |
See Remarks |
2018-01-31 |
14,078,012 |
2017-05-04 |
14,175,551 |
Premium* |
|
|
Amyris, Inc. |
AMRS |
10% Owner |
2018-05-07 |
3,207,423 |
2016-10-14 |
0 |
Premium* |
|
|
Virtu Financial Inc |
VIRT |
10% Owner |
2017-07-20 |
0 |
2020-05-13 |
11,380,503 |
Premium* |
|
|
Coherus Biosciences, Inc. |
CHRS |
10% Owner |
2019-12-30 |
7,381,116 |
|
0 |
Premium* |
|
|
Lumen Technologies, Inc |
LUMN |
10% Owner |
2018-04-03 |
0 |
2019-01-16 |
107,201,207 |
Premium* |
|
|
Guardant Health, Inc. |
GH |
10% Owner |
2018-10-09 |
0 |
2018-10-09 |
596,012 |
Premium* |
|
|
Dell Technologies Inc |
DELL |
Former 10% Owner |
2019-08-30 |
0 |
2019-09-03 |
15,513,516 |
Premium* |
|
|
Sqz Biotechnologies Co |
SQZ |
10% Owner |
2020-11-03 |
0 |
2020-11-03 |
2,513,924 |
Premium* |
|
|
Flywire Corp |
FLYW |
10% Owner |
2021-05-28 |
1,873,320 |
2021-05-28 |
0 |
Premium* |
|
|
Blend Labs, Inc. |
BLND |
10% Owner |
2021-07-20 |
11,875,773 |
2021-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EQIX |
Equinix Inc |
10% Owner |
– – • |
2005-11-16 |
4 |
S |
$32.12 |
$327,312,769 |
I/I |
(10,189,549) |
0 |
|
- |
|
| EQIX |
Equinix Inc |
10% Owner |
– – • |
2008-11-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,821,910 |
0 |
0 |
- |
|
| LVLT |
Level 3 Communications In... |
10% Owner |
– – • |
2017-11-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(65,031,667) |
0 |
0 |
- |
|
| FLYW |
Flywire Corp |
10% Owner |
– – • |
2021-05-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,508,893) |
0 |
0 |
- |
|
| GH |
Guardant Health, Inc. |
10% Owner |
– – • |
2018-10-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,613,007 |
596,012 |
0 |
- |
|
| EQIX |
Equinix Inc |
10% Owner |
– – • |
2008-11-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,821,910 |
656,180 |
0 |
- |
|
| FLYW |
Flywire Corp |
10% Owner |
– – • |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
11,387,613 |
1,873,320 |
0 |
- |
|
| FLYW |
Flywire Corp |
10% Owner |
– – • |
2021-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,508,893 |
1,873,320 |
0 |
- |
|
| SQZ |
Sqz Biotechnologies Co |
10% Owner |
– – • |
2020-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,888,924 |
1,888,924 |
0 |
- |
|
| SQZ |
Sqz Biotechnologies Co |
10% Owner |
– – • |
2020-11-03 |
4 |
B |
$16.00 |
$10,000,000 |
I/I |
625,000 |
2,513,924 |
1.5 |
- |
|
| EQIX |
Equinix Inc |
10% Owner |
– – • |
2003-11-21 |
4 |
B |
$20.00 |
$37,714,560 |
I/I |
1,885,728 |
2,982,132 |
1.5 |
- |
|
| AMRS |
Amyris, Inc. |
10% Owner |
– – • |
2018-05-07 |
4 |
S |
$6.54 |
$622,635 |
D/D |
(95,162) |
3,207,423 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-21 |
4 |
S |
$2.68 |
$134,893 |
D/D |
(49,500) |
4,035,424 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-20 |
4 |
S |
$2.25 |
$36,269 |
D/D |
(15,748) |
4,084,924 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
10% Owner |
– – • |
2017-06-01 |
4 |
S |
$34.40 |
$58,480,000 |
D/D |
(1,700,000) |
4,133,568 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-15 |
4 |
S |
$2.25 |
$49,864 |
D/D |
(22,104) |
4,145,452 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-14 |
4 |
S |
$2.25 |
$104,698 |
D/D |
(46,500) |
4,167,556 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-08 |
4 |
S |
$2.38 |
$308,992 |
D/D |
(129,600) |
4,322,809 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-05-07 |
4 |
S |
$2.36 |
$484,947 |
D/D |
(205,260) |
4,452,409 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-04-29 |
4 |
S |
$2.28 |
$279,021 |
D/D |
(122,410) |
4,657,669 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2009-04-28 |
4 |
S |
$2.53 |
$505,740 |
D/D |
(200,000) |
4,780,079 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
10% Owner |
– – • |
2006-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,980,079 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
10% Owner |
– – • |
2014-10-08 |
4 |
B |
$26.00 |
$41,600,000 |
D/D |
1,600,000 |
5,833,568 |
2.45 |
- |
|
| CHRS |
Coherus Biosciences, Inc. |
10% Owner |
– – • |
2017-08-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,556,116 |
|
- |
|
| PTLA |
Portola Pharmaceuticals I... |
10% Owner |
– – • |
2015-12-09 |
4 |
B |
$48.00 |
$36,000,000 |
I/I |
750,000 |
6,583,568 |
1.5 |
- |
|
141 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
